NCT05325957

Brief Summary

the purpose of this study is to assess the effect of norepinephrine and fluid expansion on capillary refill time during septic shock.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started May 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 13, 2022

Completed
18 days until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

August 16, 2024

Status Verified

August 1, 2024

Enrollment Period

2.1 years

First QC Date

April 6, 2022

Last Update Submit

August 13, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference of capillary refill time before and after the therapeutic change

    Capillary refill time (CRT) is time required for return of color after application of blanching pressure to a distal capillary bed. In this study, we made a calibrated compression of the skin using a piston for seven seconds, and we recorded CRT with a smartphone's video camera.

    Change from capillary refill time between the 15 min before the therapeutic, Immediately after fluid administration and within the 15 minutes of a change in norepinephrine dose

Secondary Outcomes (3)

  • Correlation between capillary refill time and perfusion index

    Change from capillary refill time between the 15 min before the therapeutic, Immediately after fluid administration and within the 15 minutes of a change in norepinephrine dose

  • Least significant change of capillary refill time

    Change from capillary refill time between the 15 min before the therapeutic, Immediately after fluid administration and within the 15 minutes of a change in norepinephrine dose

  • Difference between capillary refill time on thorax and on the index finger tip

    Change from capillary refill time between the 15 min before the therapeutic, Immediately after fluid administration and within the 15 minutes of a change in norepinephrine dose

Study Arms (2)

Norepinephrine variation

Patients with septic shock, cardiac output monitoring device with the PICCO2 system or swan ganz catheter and decision by the physician in charge to modify the norepinephrine dose.

Fluid infusion

Patients with septic shock, cardiac output monitoring device with the PICCO2 system or swan ganz catheter and decision by the physician in charge to give fluid infusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with septic shock, cardiac output monitoring device with the PICCO2 system or swan ganz catheter

You may qualify if:

  • Septic shock
  • Presence of a cardiac output monitoring
  • Decision by the physician in charge to perform vascular filling or modification the norepinephrine dose

You may not qualify if:

  • Patient under a tutelage measure or placed under judicial protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Intensive Care Unit

Angers, Maine-et-Loire, 49100, France

Location

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Pierre ASFAR, M.D- Ph.D

    Angers CHU

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 13, 2022

Study Start

May 1, 2022

Primary Completion

June 1, 2024

Study Completion

June 1, 2024

Last Updated

August 16, 2024

Record last verified: 2024-08

Locations